Ibrahim Hamizah, Lim Ya Chee
PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei Darussalam.
Oncol Rev. 2020 Jul 9;14(2):454. doi: 10.4081/oncol.2020.454. eCollection 2020 Jul 6.
Colorectal cancer (CRC) is one of the leading causes of cancerrelated death worldwide. Despite progress in treatment of cancers, CRC with mutations are resistant towards anti-EGFR treatment. MicroRNAs have been discovered in an exponential manner within the last few years and have been known to exert either an onco-miRNA or tumor suppressive effect. Here, the various roles of microRNAs involved in the initiation and progression of -regulated CRC are summarized. A thorough understanding of the roles and functions of the plethora of microRNAs associated with in CRC will grant insights into the provision of other potential therapeutic targets as well as treatment. MicroRNAs may also serve as potential molecular classifier or early detection biomarkers for future treatment and diagnosis of CRC.
结直肠癌(CRC)是全球癌症相关死亡的主要原因之一。尽管癌症治疗取得了进展,但具有特定突变的CRC对抗表皮生长因子受体(EGFR)治疗具有抗性。在过去几年中,微小RNA以指数方式被发现,并且已知其发挥癌基因微小RNA或肿瘤抑制作用。在此,总结了微小RNA在调控的CRC起始和进展中所涉及的各种作用。深入了解与CRC相关的大量微小RNA的作用和功能,将有助于深入了解提供其他潜在治疗靶点以及治疗方法。微小RNA也可能作为未来CRC治疗和诊断的潜在分子分类器或早期检测生物标志物。